A few pills twice a day keep ALK-positive non-small-cell lung cancer at bay

類似資料

• Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLC
  著者:: Landi, Lorenza, 等
  出版事項: (2016)
• Writing in PROSE proteomic-based selection for second line treatment in non-small-cell lung cancer
  著者:: Landi, Lorenza, 等
  出版事項: (2015)
• Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer
  著者:: Ourania Romanidou, 等
  出版事項: (2016-05-01)
• Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer
  著者:: Romanidou, Ourania, 等
  出版事項: (2016)
• Small distances can keep bacteria at bay for days
  著者:: van Bunnik, Bram A. D., 等
  出版事項: (2014)